Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MonoSol Rx LLC

www.monosolrx.com

Latest From Biota Holdings Ltd.

Deals Of The Week Road Tests Biopharma’s Options

The industry has pulled back on experimentation with option-to-license deals; results have been mediocre and biotechs, no longer as cash-strapped as they were in 2009, when option deals peaked, have other … options. Plus deals by Roche, Endo, Pfizer, GSK and others.

BioPharmaceutical Deals

Partnering Interest In Infectious Disease Space Showing Promise Beyond HCV Hotspot

Antiviral agents and vaccines for indications beyond the red-hot hepatitis C indication highlight the infectious diseases track at this year’s Therapeutic Area Partnerships conference.

BioPharmaceutical Clinical Trials

Deals Shaping The Medical Industry, May 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Australia’s Biota To Become U.S. Company Through Merger With Nabi

Biota and Nabi have proposed a merger that will give the Australian company access to the U.S. biotech market and increase its cash on hand.

BioPharmaceutical Australia
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • OTC, Consumer
  • Therapeutic Areas
  • Gastrointestinal
  • Gynecological, Urological
  • Immune Disorders
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • MonoSol Rx Inc.
  • MonoSol LLC
  • Kosmos Pharma
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MonoSol Rx LLC
  • Senior Management
  • Keith J Kendall, CEO
    John T Maxwell, CFO
    Mark Schobel, Chief Innovation & Technology Officer
  • Contact Info
  • MonoSol Rx LLC
    Phone: (908) 941-1900
    30 Technology Dr.
    Warren, NJ 07059
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register